ICLR News and Press, ICON plc From 08/12/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The search for growth stocks is always on for many investors. While sentiment for many high-growth stocks is at rock-bottom levels, many growth investors now have opportunities available at much more attractive prices. Th...

We established a position in ICON Plc, the second largest participant in the $50 billion Contract Management Organization (CMO) market. We believe that there remains a long runway for further drug development services to be outsourced to the CMO industry. ICLR is yet to fully capi...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Asset Fund (the “Fund”) fell 21.09% (Institutional Shares) in the quarter. We believe that Baron ...

ICON delivered a solid Q2 FY22 earnings with upsides in revenue, although missed consensus EPS. The company is a long-term cash compounder that averages triple-digit FCF conversion on a sequential basis. It has also consistently generated a positive return on capital in the years ...

The following slide deck was published by ICON Public Limited Company in conjunction with their 2022 Q2 earnings call. For further details see: ICON Public Limited Company 2022 Q2 - Results - Earnings Call Presentation

ICON Public Limited Company (ICLR) Q2 2022 Earnings Conference Call July 28, 2022 8:00 A.M. ET Company Participants Kate Haven - Vice President Investor Relations Brendan Brennan - Chief Financial Officer Steve Cutler - Chief Executive Officer Conference Ca...

Icon press release ( NASDAQ: ICLR ): Q2 GAAP EPS of $1.41 misses by $0.23 . Revenue of $1.93B (+121.5% Y/Y) in-line. Net business wins in the quarter of $2,323 million; a net book to bill of 1.20, and 1.25 on a trailing twelve month basis. Closing backlog of $2...

Icon ( NASDAQ: ICLR ) is scheduled to announce Q2 earnings results on Wednesday, July 27th, after market close. The consensus EPS Estimate is $2.79 (+31.6% Y/Y) and the consensus Revenue Estimate is $1.93B (+121.5% Y/Y). Over the last 2 years, ICLR has beaten EPS est...

West Pharmaceutical Services has performed extraordinarily well in recent years. The future of the enterprise looks bright and the company will likely continue to fare well in the years to come. But given how pricey shares are today, buying it won't make sense to a lot of investor...

BAMCO’s 13F portfolio value decreased from $47.14B to $40.75B this quarter. Ron Baron increased Spotify and Shopify while reducing Alphabet and Amazon.com. Their top five positions are at ~29% of the overall portfolio. For further details see: Tracking Ron Baron's...